Allopurinol therapy in post-kala-azar dermal leishmaniasis.
Ramesh
V
V
D000293:Adolescent; D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use*; D000963:Antimetabolites / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017496:Hypopigmentation / Q000188:drug therapy / Q000469:parasitology; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000209:etiology; D007898:Leishmaniasis, Visceral / Q000150:complications*; D008297:Male; D012074:Remission Induction
D000963:Antimetabolites; D000981:Antiprotozoal Agents; D000493:Allopurinol